| Max I Hamburger, MD | |
|
1895 Walt Whitman Rd, Melville, NY 11747-3031 | |
| (631) 249-9525 | |
| (631) 420-1526 |
| Full Name | Max I Hamburger |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 51 Years |
| Location | 1895 Walt Whitman Rd, Melville, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023004876 | NPI | - | NPPES |
| 00434579 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 121178 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rheumatology Associates Of Li Llp | 6103810791 | 11 |
News Archive
Siemens Healthineers and Biogen announced today that the companies plan to jointly develop Magnetic Resonance Imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has been at the forefront of delivering therapies to MS patients.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014.
Mammography, which is an x-ray picture of the breast, is efficient also for women over the age of 70. For women invited to regular mammography screening over the age of 70, the reduction in mortality rate was significant. This according to a vast new study from Sweden.
› Verified 1 days ago
| Entity Name | Rheumatology Associates Of Li Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689660573 PECOS PAC ID: 6103810791 Enrollment ID: O20070313000490 |
News Archive
Siemens Healthineers and Biogen announced today that the companies plan to jointly develop Magnetic Resonance Imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has been at the forefront of delivering therapies to MS patients.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014.
Mammography, which is an x-ray picture of the breast, is efficient also for women over the age of 70. For women invited to regular mammography screening over the age of 70, the reduction in mortality rate was significant. This according to a vast new study from Sweden.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Max I Hamburger, MD 315 Middle Country Rd, Smithtown, NY 11787-2817 Ph: (631) 656-7161 | Max I Hamburger, MD 1895 Walt Whitman Rd, Melville, NY 11747-3031 Ph: (631) 249-9525 |
News Archive
Siemens Healthineers and Biogen announced today that the companies plan to jointly develop Magnetic Resonance Imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions, which for two decades has been at the forefront of delivering therapies to MS patients.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
Syneron Medical Ltd., a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014.
Mammography, which is an x-ray picture of the breast, is efficient also for women over the age of 70. For women invited to regular mammography screening over the age of 70, the reduction in mortality rate was significant. This according to a vast new study from Sweden.
› Verified 1 days ago
Clifford Weingarten, Rheumatology Medicare: Medicare Enrolled Practice Location: 2 Leefield Gate, Melville, NY 11747 Phone: 631-427-7651 Fax: 631-549-1526 | |
Dr. Patricia R. Burris-warmoth, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 80 Marcus Dr, Provider Enrollment, Melville, NY 11747 Phone: 631-391-7889 Fax: 631-454-4163 | |
Dr. Roy M Shanon, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 616 Bardini Dr, Melville, NY 11747 Phone: 516-316-0983 Fax: 631-423-1949 | |
Dr. Sonia Karima Qadir, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 900 Walt Whitman Rd, Suite 101, Melville, NY 11747 Phone: 631-271-3075 Fax: 631-271-3018 | |
Dr. Evelina Kahn-kapp, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 19 Yarmouth St, Melville, NY 11747 Phone: 631-549-1620 | |
Dr. Alvin Dennis Holcomb, M.D. Rheumatology Medicare: Medicare Enrolled Practice Location: 100 W Farm Dr, Melville, NY 11747 Phone: 631-491-4982 |